69 related articles for article (PubMed ID: 19625752)
1. Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer's disease.
Ji L; Chauhan A; Wegiel J; Essa MM; Chauhan V
J Alzheimers Dis; 2009; 18(1):105-11. PubMed ID: 19625752
[TBL] [Abstract][Full Text] [Related]
2. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects.
Ji L; Chauhan V; Mehta P; Wegiel J; Mehta S; Chauhan A
J Alzheimers Dis; 2010; 22(2):609-17. PubMed ID: 20847428
[TBL] [Abstract][Full Text] [Related]
3. Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease.
Chauhan V; Ji L; Chauhan A
Biogerontology; 2008 Dec; 9(6):381-9. PubMed ID: 18704746
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein.
Ji L; Chauhan A; Chauhan V
Neuroreport; 2008 Mar; 19(4):463-6. PubMed ID: 18287947
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of cytoplasmic gelsolin, an amyloid-beta-binding protein, under oxidative stress conditions: involvement of protein kinase C.
Ji L; Chauhan A; Chauhan V
J Alzheimers Dis; 2010; 19(3):829-38. PubMed ID: 20157239
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms.
Karelson E; Fernaeus S; Reis K; Bogdanovic N; Land T
J Neurosci Res; 2005 Feb; 79(3):368-74. PubMed ID: 15614786
[TBL] [Abstract][Full Text] [Related]
7. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
8. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
9. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
Resende R; Moreira PI; Proença T; Deshpande A; Busciglio J; Pereira C; Oliveira CR
Free Radic Biol Med; 2008 Jun; 44(12):2051-7. PubMed ID: 18423383
[TBL] [Abstract][Full Text] [Related]
10. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
11. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
[TBL] [Abstract][Full Text] [Related]
12. Evidence for apoptotic cell death in Alzheimer's disease.
Smale G; Nichols NR; Brady DR; Finch CE; Horton WE
Exp Neurol; 1995 Jun; 133(2):225-30. PubMed ID: 7544290
[TBL] [Abstract][Full Text] [Related]
13. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
Hellström-Lindahl E; Ravid R; Nordberg A
Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
16. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
17. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
Piñero DJ; Hu J; Connor JR
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
[TBL] [Abstract][Full Text] [Related]
19. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.
Feng Z; Qin C; Chang Y; Zhang JT
Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883
[TBL] [Abstract][Full Text] [Related]
20. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
